FDA Import Refusal 799-9017753-6/11/1 — Glaxosmithkline Argentina S.A.
The FDA refused shipment 799-9017753-6/11/1 from Glaxosmithkline Argentina S.A. (Argentina) on June 7, 2022. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 7, 2022
- Country
- Argentina
- Product Category
- Drugs and Biologics
- Product Code
- 62GAY99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 118,3280,75